Skip to main content
Caplight Logo









Telescope Therapeutics

Telescope Therapeutics

Private
MontrealHealthcare & Life Scienceshttps://www.telescopetherapeutics.com/

Last Round

Accelerator

Nov 14, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Telescope Therapeutics is a biotechnology company that develops a drug discovery platform using human iPSC-derived disease models and biosensor-based phenotypic evaluation to identify treatments for fibrotic diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

iPSCinduced pluripotent stem celldrug discoverydisease-in-a-dishphenotypic screeningfibrotic diseasebiosensorpreclinical researchself-driving labSDLbiotech platformcontract researchlab automationprecision pharmacology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Telescope Therapeutics Comparables

Compare Telescope Therapeutics with similar companies based on industry and business-model similarity.

Telescope Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Curi Bio
79%
HeartBeat.bio AG
78%
Vivodyne
78%

Telescope Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 14, 2025

Key People

Founding team and executive leadership

Myriam Lavoie

Chief Executive Officer

Executive Team

Telescope Therapeutics Investors

Notable investors and investment history

Telescope Therapeutics investors
InvestorRounds
LvlUp VenturesAccelerator
McGill Dobson Centre for EntrepreneurshipAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 14, 2025

    Secured funding from LvlUp Ventures and McGill Dobson Centre for Entrepreneurship.

  • Jul 17, 2025

    Grew 75% QoQ, from 4 to 7 employees.

Telescope Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Telescope Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Telescope Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal
Employee Range3
Year FoundedN/A
Last FundingNov 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?